Differential Expression of Chemokines, Risk of Stable Coronary Heart Disease, and Correlation with Established Cardiovascular Risk Markers
- 1 January 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (1) , 194-199
Abstract
Objective— We investigated the association of several chemokines with the risk of stable coronary heart disease (CHD) in a large case-control study after adjustment for other established risk factors. Furthermore, we analyzed their correlation with various acute-phase proteins, inflammation-associated cytokines, and an adhesion molecule. Methods and Results— We included 312 patients aged 40 to 68 years with angiographically confirmed and stable CHD and 472 age- and gender-matched controls in this study. The main outcome measure was the odds ratio (OR) for CHD associated with increased levels of interferon (INF)-inducible protein of 10 kd (IP-10), interleukin (IL)-8, regulated on activation normal T-cell expressed and secreted (RANTES), monocyte chemoattractant protein 1 (MCP-1), macrophage inflammation protein 1α (MIP-1α), or eotaxin determined by rigidly evaluated sandwich ELISAs. Serum levels of IP-10 and IL-8 were higher, and serum levels of RANTES were lower in CHD patients when compared with age- and gender-matched controls. In addition, values in the second and top tertile of IP-10 and IL-8 were associated with an increased OR for CHD when compared with values in the bottom tertile [OR for IP-10 (top tertile) was 2.62 (95% CI, 1.79 to 3.85) in the age- and gender-adjusted model and 1.93 (95% CI, 1.23 to 3.04) in the fully adjusted model, and for IL-8, the OR was 1.77 (95% CI, 1.20 to 2.59) and 1.53 (95% CI, 0.98 to 2.39), respectively]; increased RANTES values were associated with a lower OR for CHD [OR, 0.67 (95% CI, 0.47 to 0.96) and 0.61 (95% CI, 0.40 to 0.94)]. Furthermore, positive correlations of IP-10 and IL-8 with several acute-phase proteins or inflammation-associated cytokines were evident, and positive correlations for IP-10 plasma viscosity and intercellular adhesion molecule 1 were also present. Conclusions— The current study suggests that there may be no universal upregulation of chemokines in CHD-associated inflammation but different upregulation of IP-10 and IL-8 versus downregulation of RANTES; there was no clear disease association for MCP-1, MIP-1α, or eotaxin.Keywords
This publication has 25 references indexed in Scilit:
- Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarctionAtherosclerosis, 2005
- ChemokinesArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Physical Activity, Coronary Heart Disease, and Inflammatory ResponseArchives of internal medicine (1960), 2003
- Seropositivity to chlamydial lipopolysaccharide and chlamydia pneumoniae, systemic inflammation and stable coronary artery diseaseJACC, 2000
- Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cellsJournal of Clinical Investigation, 1999
- Expression and Cellular Localization of the CC Chemokines PARC and ELC in Human Atherosclerotic PlaquesThe American Journal of Pathology, 1999
- Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart DiseaseJAMA, 1998
- Interferon-inducible Protein-10 Involves Vascular Smooth Muscle Cell Migration, Proliferation, and Inflammatory ResponseJournal of Biological Chemistry, 1996
- Leucocyte-endothelial interactions and regulation of leucocyte migrationThe Lancet, 1994
- Interleukin-6 and the acute phase responseBiochemical Journal, 1990